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1.0 Introduction 
We report the thermodynamic effects of heavy water and intramolecular deuteration 
on the melting and aggregation of fatted and defatted human serum albumin (FHSA 
and DFHSA) in 250mM salt.  Eight different combinations with and without 
deuterium were produced by recombinant expression of the proteins in the yeast 
Pichia pastoris. Human serum albumin is 47% of the protein in blood and is an 
important carrier of fat and medicines throughout the body. It is a potential carrier of 
invasive nanoparticles. The x-ray crystal structures of the molecule in its native and 
recombinant forms, with and without the fat molecule, and with drug molecules have 
been determined to 1.8Å resolution by x-ray diffraction [1,2,3]. The structures of the 
fatted and defatted molecules in this 67kD molecule are very similar and the local 
conformational changes associated with the fat ligand as well as drug molecules are 
established.  
 
It is well known that the structures of fully deuterated proteins and their hydrogenous 
counterparts are closely similar [4,5,6,7] and so it was a surprise, in 2013, that strong 
aggregation of a fully deuterated sample of human serum albumin in heavy water 
buffer was found at the outset of a neutron experiment to study the protein corona 
around silica nanoparticles.  
 
 
Figure 1 shows the Dynamic Light Scattering at 25°C in heavy water PBS from a 
1mg/ml solution of “native” fatted human serum albumin (red) and a 1mg/ml 
heavy water solution of recombinant fully deuterated, defatted human serum 
albumin (black). 
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2.1 Methods 
To understand this problem the relatively insensitivity of the native forms to 
aggregation in D2O was established [8]. Subsequently in 2014, eight recombinant per-
deutero and proto FHSA and DFHSA in 150mM salt tris buffer showed significant 
and varied aggregation in a period of about a week at about 25°C. Furthermore, the 
extent of aggregation was dependent on the placement of the deuterium [9]. In 2016 
the whole experiment was repeated with highly stabilised HSAs using; the 
recombinant expression developed by Belew et al (10) in high salt (250mM). During 
the synthesis 10mM sodium caprylate [11,12] was added for stabilisation and added 
cysteine (10mM) to block any association by the sulf-hydril linkages. In a parallel 
synthesis the fully hydrogenous protein was expressed and parts of both recombinant 
protein solutions were defatted as different deuterium effects were expected for FHSA 
and DFHSA because of different reactivity [13] and isoelectric points (FHSA 4.8 and 
DFHSA 5.6 [14]. The synthesis is set out in Figure 2 with the final light or heavy 
water buffer containing 250mM NaCl, 1mM DTT and 0.1M potassium phosphate. 
 
Figure 2 The two syntheses and their Fatted and Defatted human serum albumin 
products. 
 
The in solution melting and aggregation in high salt (250mM) of these compounds as 
determined by differential scanning fluorometry using a Nanotemper Prometheus 
NT.48. The “NanoTemper” method [15] is presented here to quantify the variable 
effects of solvent and intra-molecular deuteration found previously. The permutation 
of deuterium labelling is listed in Table 1. The pH is as measured on the meter and the 
0.4 pH units to show the real acidity, have not been added [16]. 
 
TABLE 1 
Recombinant Human Serum albumins, concentrations, pH 
 
Concentration  mg/ml pH  
I - HHSA Defatted D2O Buffer 1.1 6.74 
J - HHSA Defatted H2O Buffer 1 7.18 
K - HHSA Fatted D2O buffer 1.1 6.74 
L - HHSA Fatted H2O Buffer 1 7.18 
M -  FDHSA Defatted D2O Buffer 1.2 6.74 
N -  FDHSA Defatted H2O Buffer 1 7.18 
O - FDHSA Fatted D2O Buffer 1.1 6.74 
P - FDHSA Fatted H2O Buffer 1 7.18 
 
3.0 Results 
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Protein Melting in solution 
The form of the NanoTemper melting curves from the instrument and their first 
derivatives are shown in Figure 3. The 250mM salt solutions provide thermodynamic 
data for the eight recombinant and the native fatted (Sigma-Aldrich A8763) and 
defatted (Sigma-Aldrich A1887) proteins – used as a comparison for the effect of fat. 
The data were recorded between 20°C and 95°C at a scanning rate of 1°C per minute. 
The results are shown in Table 2. 
 
 
Figure 3 Melting curves F350/330 fluorescence intensity ratios 
(upper) and the differential (below) to show the melting 
temperature and onset. 
 
TABLE 2 
Melting Temperatures for eight recombinant human serum albumins 
 
From IGOR replots 
T1/°C T2/°C 
Native Fatted HSA 68.7 
Native Defatted HSA 66.2 
I - HHSA Defatted D2O Buffer 70.3 87 
K - HHSA Fatted D2O buffer 71.0 82 
J - HHSA Defatted H2O Buffer 66.8 87 
L - HHSA Fatted H2O Buffer 66.9 85 
M - FDHSA Defatted D2O Buffer 69.2 - 
O - FDHSA Fatted D2O Buffer 68.9 86 
N - FDHSA Defatted H2O Buffer 64.9 90 
P- FDHSA Fatted H2O Buffer 64.9 89 
  
The expected stabilisation [11,12] by the fatty acid ligand of about 3°C for the native 
forms appears with a T1 of 68.7°C for the fatted and 66.2°C for the defatted HSA.. 
The recombinant data fall into four groups of two proteins each, i.e. I/K, J/L, M/O and 
N/P. The similarity of the melting function within these groups is striking as is the 
absence of the 3°C shift from fatted to defatted change – an explanation for which 
might be that the defatting step in the synthesis may not have been successful. 
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Changing from light to heavy water buffer increases T1by 3.3°C and 3.5°C for 
samples I/K vs. J/L and M/O vs. N/P, respectively. Intramolecular deuteration on the 
other hand decreases the unfolding temperature by 1.9°C and 2.9°C for samples J/L 
vs. N/P and I/K vs. M/O, respectively.  
 
Thermodynamics  
The melting points, T1, of I…P solutions are 3°C or 4°C higher in D2O compared to 
H2O for both the fatted and “defatted” molecules. and the highest T1 of all - for the 
deuterated molecule, shows that there is a solvent and an intra-molecular deuterium 
effect present - about (+3°C rise for the solvent and an extra 1°C attributable to 
molecular deuteration.  
 
The van’t Hoff enthalpies and entropies, ∆H and ∆S, of melting can be calculated in 
principle, from the fluorescence intensity ratios of the melting curves, F350/330, 
as a function of temperature [17,18,19]. To obtain the van’t Hoff curves, the as-
measured fluorescence ratio from each sample, normalised to unity and then the 
fractional fluorescence ratio at any given temperature subtracted from unity and ln 
plotted – versus the reciprocal of absolute temperature (Figure 4) and the straight-line 
portion used.  In fact the noisiness of the data makes the choice of background very 
difficult.  
 
Figure 4 Van’t Hoff melting curves for the eight recombinant proteins. 
 
There are four groups and the almost co-incidence of fatted and defatted results – is 
clear. For the range -3 <ln(ratio) <-1.5 the slopes lead to ∆H with associated ∆S 
shown in Table 3 . We quote the enthalpies of melting to ± 50kJ//mole for reasons of 
caution all are in the range quoted by Lang and Cole [11]. The ∆H for hydrogenous 
molecules are less negative than for the deuterated molecules by ca 50 to 100kJ/mole 
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and the effect of the deuterated buffer looks to be a stabilisation of ca. 50kJ/mole – 
except for I and J. 
Table 3 van’t Hoff Enthalpies and Entropies of Melting 
∆Η kJ/m Tm/K 
∆S 
J/m/K 
I - HHSA Defatted D20 Buffer orange 469 343 1370 
J - HHSA Deffated H20 Buffer green 415 340 1220 
K-HHSA Fatted D20 buffer light blue 460 343 1340 
L -HHSA Fatted H20 Buffer  Mid blue 476 340 1400 
M -FDHSA Defatted D20 Buffer dark blue 481 342 1410 
N- FDHSA Defatted H20 Buffer black 568 338 1680 
O - FDHSA Fatted D20 Buffer carmine 517 342 1510 
P-  FDHSA Fatted H20 Buffer rose 583 338 1730 
 
 Alternatively to the van’t Hoff method of finding the slope we have used the whole 
melting function in upper part of Figure 3(a). This was fitted by equation 23 in [20] 
using MagicplotPro. Each sample I to P was fitted independently, and then the 
respective “defatted”/fatted pairs were averaged for the reasons explained above.  The 
enthalpies are lower the above by about 100kJ/mole but the results are not far away 
from the published values of Picó [21] and Flora [22].  
Table 4 (A) van’t Hoff Enthalpies and Entropies of Melting 
 
 ∆H [kJ/mol] ∆S [J/K∙mol] Tm [°C] Tm [°C]a 
HHSA/D2O buffer (I/K) 204±3 593±10b 344±2 70.7±0.5 
HHSA/H2O buffer (J/L) 326±9 954±30b 342±4 66.9±0.1 
FDHSA/D2Obuffer (M/O) 239±3 699±10b 342±2 69.1±0.2 
FDHSA/H2O buffer (N/P) 326±6 965±20b 338±3 64.9±0.0 
Defatted HSA (Flora/Trp)d 350 1050 60  
Defatted HSA (Picó/Trp)c 377  62.1  
Defatted HSA (Picó/DSC)d 376  63.2  
aTm obtained from first derivative, b Tm calculated from ∆G = ∆H−Tm∆S = 0, c[21], 
d[22]. 
Table 4 shows that the values for ∆H are similar to those reported before by Picó and 
Flora for defatted HSA [(21,22] but fall on the lower end of a broad range of melting 
enthalpies reported by Lang & Cole for other recombinant HSA molecules [11], 
where, especially fatted HSA proteins show somewhat higher ∆H values.  
Provisionally, we accept the lower values produced by defining the background from 
the whole melting curves at the two wavelengths as a function of temperature as 
likely to identify the 1 and 0 positions around the melting transition given the wide 
spread of ∆H from the first method (subtracting a background defined by the lowest 
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point on the pre-calculated F350/330 ratio. Better statistics would achieve this.  
We give, however, a Table from the Lang & Cole paper for comparison. 
 
Table 5 van’t Hoff Enthalpies and Entropies of Melting for 
recombinant human serum albumins [11] 
 
 T1/°C T2/°C Delta 
H/kJ/m 
Delta 
SJ/m/K 
Fatted HSA M human  86% mono, 2.2F 64.2 70.8 486±4 1440 
Fatted HSA N human  97.7% mono, 4.4F 66.9 72.9 667±11 1962 
Recombinant HSA E-1 97.3% 0.2 67.8 78.2 287±24 842 
DefattedHSAI-1 human 99.5% 0.24 69.5 81.1 398±33 1162 
 
Conclusions 
 
The recombinant expression method of Belew et al [10] combined with a high salt 
medium has produced deuterated and protonated forms of human serum albumin of 
increased stability. These proteins show different melting points depending on the 
degree of deuteration in the molecule and in the solvent and this reproduces the 
qualitative effects seen by others for solvent and side chain deuteration in the melting 
points. The values of the melting enthalpies are in the ranges found by others 
[11,17,18,19] for a series of recombinant and native hydrogenous HSA and other 
proteins.  
 
The literature describes effects on thermal denaturation, proteolytic cleavage 
and aggregation arising from intra-molecular deuteration and change of solvent 
to heavy water.  That change combines a purely solvent effect (from the cohesive 
differences between H2O and D2O) with partial proton exchange in the molecular 
structure. The experiments on glutathione S-transferase (GST) by Brockwell et al 
[23,24] show the perdeuterated protein to be less stable to heat denaturation 
and cleavage than the proto form but the per-deuterated form associates into 
dimers and not the proto-form.  
 
Van Well and colleagues’ calorimetric studies [19] show that both hard and soft 
proteins are more stable against thermal denaturation in D2O than H2O and 
attribute this to a larger hydrophobic effect in D2O on the nonpolar amino acids 
of the protein.  Bhattacharya et al. [25] using circular dichroism conclude that 
heavy water causes a 20% decrease in the helical structure and, from a study of 
the solvent dynamics of the binding to coumarin 153 find a markedly retarded 
binding rate in D2O compared to H2O.  
 
The clear H2O/D2O isotope effect on bovine serum albumin denaturation seen by 
Sabounji et al. [26] using far UV circular dichroism showed the protein unfolding 
pathways as a function of temperature. Below 50 C the protein conformations 
are similar in H2O and D2O but heavy water retards irreversible thermal 
denaturation above that temperature. By contrast, above 90 C, D2O causes rapid 
denaturation of BSA but this is not observed in H2O. Here we distinguish 
between deuterium solvent and intramolecular deuteration. 
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